Detecting acute human immunodeficiency virus infection using 3 different screening immunoassays and nucleic acid amplification testing for human immunodeficiency virus RNA, 2006-2008.
about
Cost savings associated with testing of antibodies, antigens, and nucleic acids for diagnosis of acute HIV infectionCost-effectiveness of pooled nucleic acid amplification testing for acute HIV infection after third-generation HIV antibody screening and rapid testing in the United States: a comparison of three public health settingsHIV screening via fourth-generation immunoassay or nucleic acid amplification test in the United States: a cost-effectiveness analysisCost effectiveness of screening strategies for early identification of HIV and HCV infection in injection drug usersThe detection and management of early HIV infection: a clinical and public health emergency.HIV surveillance in a large, community-based study: results from the pilot study of Project Accept (HIV Prevention Trials Network 043).Screening acute HIV infections among Chinese men who have sex with men from voluntary counseling & testing centers.Screening for 'window-period' acute HIV infection among pregnant women in rural South Africa.Screening for acute HIV infection in South Africa: finding acute and chronic disease.Poor performance of the determine HIV-1/2 Ag/Ab combo fourth-generation rapid test for detection of acute infections in a National Household Survey in SwazilandTargeting the use of pooled HIV RNA screening to reduce cost in health department STD clinics: New York City, 2009-2011.ru2hot?: A public health education campaign for men who have sex with men to increase awareness of symptoms of acute HIV infection.Finding those at risk: acute HIV infection in Newark, NJ.Performance of rapid point-of-care and laboratory tests for acute and established HIV infection in San FranciscoRole of acute and early HIV infection in the sexual transmission of HIV.Expanded HIV testing in low-prevalence, high-income countries: a cost-effectiveness analysis for the United KingdomTowards targeted screening for acute HIV infections in British ColumbiaDetection of HIV-1 p24 at Attomole Level by Ultrasensitive ELISA with Thio-NAD Cycling.Detection of acute HIV infection: a field evaluation of the determine® HIV-1/2 Ag/Ab combo testIntegrating acute HIV infection within routine public health surveillance practices in New York City.HIV nucleic acid amplification testing versus rapid testing: it is worth the wait. Testing preferences of men who have sex with men.Performance of a fourth-generation HIV screening assay and an alternative HIV diagnostic testing algorithmUse of rapid HIV assays as supplemental tests in specimens with repeatedly reactive screening immunoassay results not confirmed by HIV-1 Western blot.Use of a multifaceted approach to analyze HIV incidence in a cohort study of women in the United States: HIV Prevention Trials Network 064 StudyUsing a Multitest Algorithm to Improve the Positive Predictive Value of Rapid HIV Testing and Linkage to HIV Care in Nonclinical HIV Test Sites.The HIV treatment cascade in acutely infected people: informing global guidelines.Re-Testing and Seroconversion Among HIV Testing and Counseling Clients in Lesotho.HIV testing and care systems focused on sexually transmitted HIV in China.Relative accuracy of serum, whole blood, and oral fluid HIV tests among Seattle men who have sex with men.HIV testing strategies: test performance is important, but not sufficient.Diagnosing acute HIV infection.HIV diagnosis and testing: what every healthcare professional can do (and why they should).The INSTI HIV-1/HIV-2 antibody test: a review.Point-of-care diagnostics, a major opportunity for change in traditional diagnostic approaches: potential and limitations.Evaluation of pooling strategies for acute HIV-1 infection screening using nucleic acid amplification testing.Clinical and public health implications of acute and early HIV detection and treatment: a scoping review.Improved matrix pooling.Screening for acute HIV infection in community-based settings: Cost-effectiveness and impact on transmissions.Rapid and sensitive detection of HIV-1 p24 antigen by immunomagnetic separation coupled with catalytic fluorescent immunoassay.Comparison of 4th-Generation HIV Antigen/Antibody Combination Assay With 3rd-Generation HIV Antibody Assays for the Occurrence of False-Positive and False-Negative Results.
P2860
Q24607025-97385DAF-8840-48D1-B0E1-BCF9F6D330EDQ28475627-D481F7FD-6838-4789-AA4E-2D13064E2A3EQ28478017-C5027BF7-579F-40D3-9165-B0C32829F2F1Q28483820-943485F1-1F80-4B31-8958-F8EA8AA53C44Q33586581-DB9DAF43-46D1-4884-A327-F6C0E3C08FD7Q34028918-AA0A4CE1-3AEB-45A0-BF5A-2C4E433FCBF5Q34110368-8E903399-5E3D-4B91-8972-8D984A8D9247Q34246869-65274D3D-3EDA-49AA-A694-872AC2CA9DF1Q34268037-DA8CD20F-D202-4B57-93D6-80917F5D617BQ34298229-A4F138FD-3A72-41D7-B12B-4FD875C7753BQ34576775-2AC95A75-E734-4AE4-8435-80CE92261DD7Q34640702-D37CE676-15AF-43C2-BA5A-492E6BC29506Q34701577-2385BE40-4399-468A-9306-5FEDE377372EQ35069399-B1F68C8E-C343-4014-91BC-FB044F4D3EA0Q35087462-C4DD11BA-4315-4616-B245-6E4A67F8F738Q35157015-5E0AFC55-70F0-4746-86B0-7B165F3EB7E2Q35203643-063BEEFF-002E-4C75-BF3F-9E2704C2C099Q35670640-7301FAD1-B1E2-4245-BAAD-B860DE4CE890Q35868122-DCAD50E3-4C1A-497A-98DA-A564D371B965Q36005278-CFCDEF6E-FA29-468D-96FC-F9DF0C11B84DQ36084431-4B362C44-23C8-4933-85EC-115206312820Q36092039-B986E2CD-DD19-4EAB-BD99-54E5290BF299Q36112849-6301F631-50E4-404A-9BA8-05075FF2E046Q36495534-9AC86162-58B8-43A5-AA50-CAE4417A6A06Q36507685-A68DBD3A-2698-4219-9C64-4D460EDBA503Q36539990-5F6D4A9C-EFE6-4FC9-82C8-D724FEEF68C1Q36588267-EF9DAAD7-F518-420E-82E7-02F9D95FAD81Q36768182-45FA70F1-F20E-4091-A763-90907853DDCDQ37402661-7F672C61-6EE1-462B-AEB7-94872CA94012Q37845848-875315E8-6C0E-49CF-B503-A6E9EF6FF769Q37965692-A15F96F9-9F00-4946-9F20-0F6912E22A19Q38076510-916F532B-3CD2-4092-BAB2-820E0C568E37Q38088369-8A92CD2B-39F9-4DF1-96BD-41A1A81F5BBAQ38258595-F3A78C84-AE8B-4D5C-A908-0088ECA4BB14Q38630017-37814E2E-7031-40FE-AC97-81C0985D07B0Q38686953-54E60C3A-92AF-47CB-A420-017E7CDB5300Q38849316-0BF20242-6E06-4CE4-A358-F54E666609BCQ39070385-83B00F7E-C4BC-4B38-A4AF-463BA2C2DC97Q40678359-85F3AEFE-3672-470E-B49B-DA48F765755AQ41280296-72F68E8D-22A7-415D-9750-5D3D3FD641F4
P2860
Detecting acute human immunodeficiency virus infection using 3 different screening immunoassays and nucleic acid amplification testing for human immunodeficiency virus RNA, 2006-2008.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Detecting acute human immunode ...... ficiency virus RNA, 2006-2008.
@ast
Detecting acute human immunode ...... ficiency virus RNA, 2006-2008.
@en
Detecting acute human immunode ...... ficiency virus RNA, 2006-2008.
@nl
type
label
Detecting acute human immunode ...... ficiency virus RNA, 2006-2008.
@ast
Detecting acute human immunode ...... ficiency virus RNA, 2006-2008.
@en
Detecting acute human immunode ...... ficiency virus RNA, 2006-2008.
@nl
prefLabel
Detecting acute human immunode ...... ficiency virus RNA, 2006-2008.
@ast
Detecting acute human immunode ...... ficiency virus RNA, 2006-2008.
@en
Detecting acute human immunode ...... ficiency virus RNA, 2006-2008.
@nl
P2093
P1476
Detecting acute human immunode ...... ficiency virus RNA, 2006-2008.
@en
P2093
Alexis Kowalski
Apurva Uniyal
Berry Bennett
Centers for Disease Control and Prevention Acute HIV Infection Study Group
Duncan Mackellar
Kathleen Gallagher
Marlene LaLota
Monica M Parker
Pat Simmons
Peter Kerndt
P356
10.1001/ARCHINTERNMED.2009.445
P407
P577
2010-01-01T00:00:00Z